{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:16Z","timestamp":1790268736944,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24116006"],"award-info":[{"award-number":["24116006"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["KF10-0039"],"award-info":[{"award-number":["KF10-0039"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["ALF 20130032"],"award-info":[{"award-number":["ALF 20130032"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["ALFGBG-142041"],"award-info":[{"award-number":["ALFGBG-142041"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["K2010-61P-21568-01-4"],"award-info":[{"award-number":["K2010-61P-21568-01-4"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["K2014-62X-14647-12-51"],"award-info":[{"award-number":["K2014-62X-14647-12-51"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbacli.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T16:11:53Z","timestamp":1459699913000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder"],"prefix":"10.1016","volume":"5","author":[{"given":"Noriko","family":"Yoshimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kakumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza M.","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M.","family":"Sellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Holm\u00e9n-Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbacli.2016.03.008_bb0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3122\/jabfm.18.4.233","article-title":"Screening for bipolar disorder in patients treated for depression in a family medicine clinic","volume":"18","author":"Hirschfeld","year":"2005","journal-title":"J. Am. Board Fam. Pract."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/ajp.152.8.1130","article-title":"Antidepressant-induced mania and cycle acceleration: a controversy revisited","volume":"152","author":"Altshuler","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.bbacli.2016.03.008_bb0025","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0165-0327(14)70004-7","article-title":"Differential diagnosis of bipolar disorder and major depressive disorder","volume":"169","author":"Hirschfeld","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbi.2014.10.001","article-title":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","volume":"43","author":"Isgren","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0050","article-title":"A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder","author":"Sellgren","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","article-title":"Mitochondrial dysfunction in bipolar disorder","volume":"2","author":"Kato","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/hmg\/ddi022","article-title":"Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis","volume":"14","author":"Iwamoto","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tins.2008.07.007","article-title":"Molecular neurobiology of bipolar disorder: a disease of \u2018mood-stabilizing neurons\u2019?","volume":"31","author":"Kato","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0070","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/sj.npp.1301671","article-title":"Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Quiroz","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2011.01.025","article-title":"Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis","volume":"45","author":"Konradi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11920-013-0425-9","article-title":"Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function","volume":"15","author":"Goldstein","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0090","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14728222.2014.940893","article-title":"Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder","volume":"18","author":"de Sousa","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.euroneuro.2015.04.023","article-title":"CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment","volume":"25","author":"Rolstad","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1819.2010.02113.x","article-title":"Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions","volume":"64","author":"Hashimoto","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2014.01.009","article-title":"Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts","volume":"160","author":"S\u00f6dersten","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.bp.113.134064","article-title":"Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study","volume":"205","author":"Li","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.205.5.410","article-title":"BDNF and proBDNF as biomarkers for bipolar disorder","volume":"205","author":"Hashimoto","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00406-014-0557-x","article-title":"Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder","volume":"265","author":"Hashimoto","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/mp.2015.54","article-title":"Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis","volume":"21","author":"Munkholm","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.euroneuro.2014.11.001","article-title":"Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls","volume":"25","author":"P\u00e5lsson","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0135","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","article-title":"Metabolomics tools for identifying biomarkers for neuropsychiatric diseases","volume":"35","author":"Quinones","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0145","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1073\/pnas.1402663111","article-title":"Effect of sleep deprivation on the human metabolome","volume":"111","author":"Davies","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0150","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1021\/ac900675k","article-title":"Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry","volume":"81","author":"Soga","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2015.217","article-title":"Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis","author":"Yoshimi","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.19","article-title":"A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study","volume":"4","author":"Koike","year":"2014","journal-title":"Translat. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbacli.2016.03.008_bb0165","doi-asserted-by":"crossref","first-page":"e73814","DOI":"10.1371\/journal.pone.0073814","article-title":"Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study","author":"Kuwabara","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0170","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00702-009-0300-3","article-title":"Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD","volume":"116","author":"Ryden","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0175","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0180","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","article-title":"Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"53","author":"Sachs","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.bbacli.2016.03.008_bb0185","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0190","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0195","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/ac990976y","article-title":"Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry","volume":"72","author":"Soga","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0200","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Soga","year":"2003","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00401706.1974.10489157","article-title":"The relationship between variable selection and data augmentation, and a method for prediction","volume":"16","author":"Allen","year":"1974","journal-title":"Technometrics"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0215","series-title":"Subset selection in regression, Chapman and Hall\/CRC","author":"Miller","year":"1974"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0220","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/CCM.0b013e318218a05b","article-title":"International validation of the out-of-hospital cardiac arrest score in the United States","volume":"39","author":"Hunziker","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0225","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","article-title":"The largest prospective warfarin-treated cohort supports genetic forecasting","volume":"113","author":"Wadelius","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R Statist Soc B"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0235","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","article-title":"Regulation of pyruvate metabolism and human disease","volume":"71","author":"Gray","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.spen.2013.10.008","article-title":"Mitochondrial dysfunction in autism","volume":"20","author":"Legido","year":"2013","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.arr.2014.05.004","article-title":"Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process","volume":"16","author":"Salminen","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tig.2012.04.002","article-title":"Epigenetics of major psychosis: progress, problems and perspectives","volume":"28","author":"Labrie","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2013.12.019","article-title":"Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders","volume":"80","author":"Kato","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/bj20030002","article-title":"N-acetylglutamate and its changing role through evolution","volume":"372","author":"Caldovic","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0265","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.3390\/ijms160613004","article-title":"The N-acetylglutamate synthase family: structure, function and mechanisms","volume":"16","author":"Shi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by l-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.bbacli.2016.03.008_bb0275","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0280","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PSY.0b013e3182689460","article-title":"Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction","volume":"74","author":"Fontoura","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","volume":"218","author":"Brown","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00406-004-0453-x","article-title":"The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder","volume":"254","author":"Yanik","year":"2004","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0295","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0300","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.biopsych.2005.03.018","article-title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels","volume":"57","author":"Yamada","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00406-013-0399-y","article-title":"Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders","volume":"263","author":"Hashimoto","year":"2013","journal-title":"Eur. Ach. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0310","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14728222.2014.934225","article-title":"Targeting of NMDA receptors in new treatments for schizophrenia","volume":"18","author":"Hashimoto","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbacli.2016.03.008_bb0315","article-title":"Increased serum levels of serine enantiomers in patients with depression","author":"Hashimoto","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00406-015-0602-4","article-title":"Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder","volume":"266","author":"Hashimoto","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.bbacli.2016.03.008_bb0325","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/s40279-014-0256-9","article-title":"Muscle energetics during explosive activities and potential effects of nutrition and training","volume":"44","author":"Sahlin","year":"2014","journal-title":"Sports Med."},{"issue":"30","key":"10.1016\/j.bbacli.2016.03.008_bb0330","article-title":"International society of sports nutrition position stand: beta-alanine","volume":"12","author":"Trexler","year":"2015","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"10.1016\/j.bbacli.2016.03.008_bb0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2014.11.058","article-title":"Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients","volume":"174","author":"Karanti","year":"2015","journal-title":"J. Affect. Disord."}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T14:43:43Z","timestamp":1762008223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214647416300125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":67,"alternative-id":["S2214647416300125"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.03.008","relation":{},"ISSN":["2214-6474"],"issn-type":[{"value":"2214-6474","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}